AgeChem: Funding, Team & Investors | Startup Intros

Loading organizations...

AgeChem: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2014	Sorbent Therapeutics	$7.0M Series D	—	ARCH Venture Partners, Flagship Ventures, NanoDimension, Polaris Partners, CMEA Capital, dRx Capital, Sofinnova Ventures
Nov 1, 2012	Alethia BioTherapeutics	$5.0M Series B	—	BDC Venture Capital, Cellscript, Go Capital
Aug 30, 2012	Aerpio Pharmaceuticals	$27.0M Series A	Campbell Murray	Athenian Venture Partners, Kearny Venture Partners, Triathlon Medical Ventures, Venture Investors
Jan 9, 2012	Akebia Therapeutics	$4.1M Series B Extension	—	Athenian Venture Partners, dRx Capital, Kearny Venture Partners, Sigvion Capital, Triathlon Medical Ventures, Venture Investors
Jun 1, 2011	Sorbent Therapeutics	$36.0M Series B	Markus Goebel	ARCH Venture Partners, Flagship Ventures, NanoDimension, Polaris Partners, David Collier, Sofinnova Ventures
Apr 1, 2011	Akebia Therapeutics	$22.0M Series B	Novartis, Venture Investors	Cincy Tech, Athenian Venture Partners, Kearny Venture Partners, Sigvion Capital, Triathlon Medical Ventures
Feb 1, 2011	Conatus Pharmaceuticals	$20.0M Series B	Louis Lacasse	Aberdare Ventures, Advent Life Sciences, Shahzad Malik, William Gerber, Roche
Sep 1, 2010	Alethia BioTherapeutics	$9.0M Series A	BDC Venture Capital, Elizabeth Douville, PhD, ICD.D, Go Capital	Amorchem, Epicentre Technologies Corporation
Sep 1, 2010	Sorbent Therapeutics	$22.0M Series B	—	ARCH Venture Partners, Flagship Ventures, NanoDimension, Polaris Partners, CMEA Capital, Sofinnova Ventures, The Dow Chemical Company